MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer.
Chi W, Xiu B, Xiong M, Wang X, Li P, Zhang Q, Hou J, Sang Y, Zhou X, Chen M, Zheng S, Zhang L, Xue J, Chi Y, Wu J.
Chi W, et al. Among authors: zhang l, zhang q.
Int J Mol Sci. 2023 Dec 22;25(1):221. doi: 10.3390/ijms25010221.
Int J Mol Sci. 2023.
PMID: 38203393
Free PMC article.